, ,

Izote Biosciences secures $2.6 million to advance an oxygen-free fermentation process.

Merima Hadžić Avatar

Precision fermentation, while innovative for creating bio-based products like chemicals, medicines, and cultivated meat, remains expensive and challenging to scale up. Izote Biosciences, a burgeoning startup, is pioneering a novel approach that allows bacteria to function anaerobically within a bioreactor. This breakthrough method led to a successful pre-seed funding round of $2.6 million in October.

Named after El Salvador’s national flower, Izote was co-founded by Victor Manuel Reyes-Umaña, a microbiologist and fermentation expert, and Samuel Atwood, a former McKinsey management consultant, in 2022. The duo aims to revolutionize the fermentation process through synthetic biology, enabling the production of cost-effective, bio-based molecules for various industries.

Izote’s method diverges significantly from traditional fermentation. Instead of relying on oxygen, it utilizes a salt-like molecule vastly more soluble than oxygen, simplifying the bioreactor design and significantly reducing costs. This innovation promises to lower capital expenses by over 70% and double gross margins, positioning Izote to disrupt the fragrance and flavor industries initially, with plans to expand into food and cosmetics.

Despite being in the pre-revenue phase, Izote has attracted significant venture capital interest, raising $2.6 million from notable investors. The company is on a mission to identify launch molecules and prove their productivity superiority within 18 months, challenging the synthetic biology sector’s norms by prioritizing economic viability from the outset.

Merima Hadžić Avatar
Search
Categories